Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

4,607 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,607 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778940
What this trial is testing

Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.

Who this might be right for
Leptomeningeal Metastasis
Tianjin Medical University Cancer Institute and Hospital 50
Not applicableUnknownNCT00607984
What this trial is testing

Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors

Who this might be right for
Central Nervous System TumorsTumors
Rabin Medical Center 20
Not applicableLooking for participantsNCT06501521
What this trial is testing

Non-invasive Brain Tumor Molecular Diagnostics and Monitoring

Who this might be right for
Brain Tumor
The Institute of Molecular and Translational Medicine, Czech Republic 200
Not applicableLooking for participantsNCT05672043
What this trial is testing

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

Who this might be right for
MedulloblastomaCentral Nervous System Tumor, PediatricEpendymoma+3 more
Beijing Tiantan Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT01906385
What this trial is testing

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Who this might be right for
Glioma
Cerenome 55
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Not applicableStudy completedNCT04320108
What this trial is testing

ESWT for Shoulder Pain in Patients With Brain Damage

Who this might be right for
Brain Damage, HypoxicStrokeBrain Tumor+1 more
Bundang CHA Hospital 6
Not applicableNot Yet RecruitingNCT06516471
What this trial is testing

The Evolution of Neuroendoscopy Guided by Head-mounted Mixed Reality Technique Navigation System in Neurosurgery

Who this might be right for
Pineal TumorBrainstem TumorSurgery
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00004147
What this trial is testing

COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Not applicableLooking for participantsNCT06835426
What this trial is testing

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Who this might be right for
Breast CarcinomaProstate Cancer SurgeryThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares 150
Not applicableActive Not RecruitingNCT03606421
What this trial is testing

CBF and NCF Changes With Brain Radiation

Who this might be right for
Neurocognitive DysfunctionBrain Metastases
University Health Network, Toronto 110
Early research (Phase 1)Study completedNCT03371004
What this trial is testing

DM-CHOC-PEN Plus Radiation for Brain Tumors

Who this might be right for
Advanced Cancer
DEKK-TEC, Inc. 19
Not applicableLooking for participantsNCT06941584
What this trial is testing

Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies

Who this might be right for
AIRE Deficiency
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Not applicableUnknownNCT01143584
What this trial is testing

Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.

Who this might be right for
Macroprolactinoma
Post Graduate Institute of Medical Education and Research, Chandigarh 20
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04223999
What this trial is testing

Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

Who this might be right for
Recurrent Glioblastoma
Anders Rosendal Korshøj 70
Large-scale testing (Phase 3)WithdrawnNCT00226668
What this trial is testing

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Who this might be right for
Brain EdemaBrain Tumor
Celtic Pharma Development Services 120
Not applicableLooking for participantsNCT06100718
What this trial is testing

Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

Who this might be right for
Cancer-related StrokeParaneoplastic CoagulopathyOccult Cancer+3 more
Insel Gruppe AG, University Hospital Bern 370
Next Page